- Five Prime Therapeutics (NASDAQ:FPRX -2.1%) announced that veteran David V. Smith will join the company as Executive Vice President and Chief Financial Officer, effective November 26, 2018.
- “We are delighted to welcome David to Five Prime. His wealth of industry and financial leadership experience will serve Five Prime and our stakeholders well,” said Aron Knickerbocker, CEO of Five Prime Therapeutics.
Five Prime Therapeutics announces David V. Smith as CFO
Recommended For You
More Trending News
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
FPRX | - | - |
Five Prime Therapeutics, Inc. |